Table 3 Number of cases that expressed (“positive cases”, 1+ to 3+) and those with “high expression” (> 25%, 2+ or 3+) for each VEGF subunit and cognate receptora
From: The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas
Positive cases N | High expression N | |
|---|---|---|
VEGF-A | 57/62 (91.9%) | 49/57 (85.9%) |
VEGF-C | 53/56 (94.6%) | 48/53 (90.5%) |
VEGF-D | 55/63 (87.3%) | 49/55 (89.0%) |
VEGF-R1 | 65/66 (98.5%) | 55/65 (84.6%) |
VEGF-R2 | 63/64 (98.4%) | 56/63 (88.8%) |
VEGF-R3 | 49/50 (98.0%) | 46/49 (93.8%) |